Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:50 AM
Ignite Modification Date:
2025-12-26 @ 10:21 AM
NCT ID:
NCT00989261
Group ID:
EG000
Title:
Cohort 1; ≥60 Years of Age
Description:
FLT3-ITD positive and negative populations will be divided into 2 cohorts as follows:
Participants ≥60 years of age who were relapsed after one first-line chemotherapy regimen (with or without consolidation) and after first complete remission \<12 months or are primary refractory to first-line chemotherapy received a starting dose of 200 mg/day quizartinib.
Exploratory: FLT3-ITD (+) and FLT3-ITD (-) Confirmatory: FLT3-ITD (+) and FLT3-ITD (-)
After an amendment, male participants received a starting dose of 135 mg/day quizartinib and all females received a starting dose of 90 mg/day.
Deaths Number Affected:
71
Deaths Number At Risk:
None
Serious Number Affected:
134
Serious Number At Risk:
157
Other Number Affected:
151
Other Number At Risk:
157
Study:
NCT00989261
Results Section:
NCT00989261
Adverse Events Module:
NCT00989261